AEMD vs. IONM, GMVDF, VERO, STSS, AFIB, TNON, INVO, QNRX, DYNT, and NMRD
Should you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include Assure (IONM), G Medical Innovations (GMVDF), Venus Concept (VERO), Sharps Technology (STSS), Acutus Medical (AFIB), Tenon Medical (TNON), INVO Bioscience (INVO), Quoin Pharmaceuticals (QNRX), Dynatronics (DYNT), and Nemaura Medical (NMRD). These companies are all part of the "surgical & medical instruments" industry.
Aethlon Medical (NASDAQ:AEMD) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, community ranking, valuation, earnings, institutional ownership and dividends.
Aethlon Medical has a beta of 1.95, meaning that its stock price is 95% more volatile than the S&P 500. Comparatively, Assure has a beta of 1.87, meaning that its stock price is 87% more volatile than the S&P 500.
In the previous week, Assure had 1 more articles in the media than Aethlon Medical. MarketBeat recorded 1 mentions for Assure and 0 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.00 equaled Assure'saverage media sentiment score.
Aethlon Medical has a net margin of 0.00% compared to Assure's net margin of -400.68%. Aethlon Medical's return on equity of -106.28% beat Assure's return on equity.
2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 3.3% of Assure shares are held by institutional investors. 4.0% of Aethlon Medical shares are held by insiders. Comparatively, 3.8% of Assure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Aethlon Medical presently has a consensus price target of $10.00, indicating a potential upside of 619.42%. Assure has a consensus price target of $4.00, indicating a potential upside of 691.45%. Given Assure's higher probable upside, analysts plainly believe Assure is more favorable than Aethlon Medical.
Aethlon Medical has higher revenue and earnings than Assure.
Aethlon Medical received 213 more outperform votes than Assure when rated by MarketBeat users. Likewise, 54.55% of users gave Aethlon Medical an outperform vote while only 27.27% of users gave Assure an outperform vote.
Summary
Aethlon Medical beats Assure on 10 of the 14 factors compared between the two stocks.
Get Aethlon Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aethlon Medical Competitors List
Related Companies and Tools
